U-Neuron Biomedical Stock

U-Neuron Biomedical FCF Margin

The Free Cash Flow Margin of U-Neuron Biomedical (6973.TWO) as of Aug 1, 2026 is -213.77 %. In the previous year, Free Cash Flow Margin was -205.75 % — a change of 3.90% (lower).

FCF Margin

-213.77 %

YoY

3.90%

Last updated:

Free Cash Flow Margin of U-Neuron Biomedical is 2026 -213.77 % . Free Cash Flow Margin of U-Neuron Biomedical was 2025 -205.75 % . It decreases by 3.90% lower compared to the previous year.
Access this data via the Eulerpool API

U-Neuron Biomedical Stock analysis

What does U-Neuron Biomedical do? U-Neuron Biomedical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about U-Neuron Biomedical stock

Free Cash Flow Margin of U-Neuron Biomedical is -213.77 % in 2026.

Access this data via the Eulerpool API

Margins — U-Neuron Biomedical

All Key Metrics — U-Neuron Biomedical